Lydie SPARFEL

Prof. Lydie SPARFEL

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2010 in Toxicological Sciences
Verified
Journal Article
Closed access
PDF file
LSLydie SPARFEL
Lydie SPARFEL
Marie-Laure Pinel-MarieMarie-Laure Pinel-Marie
Marie-Laure Pinel-Marie
MBMagali Boize
Magali Boize
SKSerge Koscielny
Serge Koscielny
SDSophie Desmots
Sophie Desmots
OFOlivier Fardel
Olivier Fardel
Polycyclic aromatic hydrocarbons (PAHs) are widely distributed immunotoxic and carcinogenic environmental contaminants, known to affect macrophages. In order to identify their molecular targets in such cells, we have analyzed gene expression profile of primary human macrophages treated by the prototypical PAH benzo(a)pyrene (BaP), using pangenomic oligonucleotides microarrays. Exposure of macrophages to BaP for 8 and 24 h resulted in 96 and 1100 genes, differentially expressed by at least a twofold change factor, respectively. Some of these targets, including the chemokine receptor CXCR5, the G protein–coupled receptor 35 (GPR35), and the Ras regulator RASAL1, have not been previously shown to be affected by PAHs, in contrast to others, such as interleukin-1β and the aryl hydrocarbon receptor (AhR) repressor. These BaP-mediated gene regulations were fully validated by reverse transcription–quantitative polymerase chain reaction assays for some selected genes. Their bioinformatic analysis indicated that biological functions linked to immunity, inflammation, and cell death were among the most affected by BaP in human macrophages and that the AhR and p53 signaling pathways were the most significant canonical pathways activated by the PAH. AhR and p53 implications were moreover fully confirmed by the prevention of BaP-related upregulation of some selected target genes by AhR silencing or the use of pifithrin-α, an inhibitor of PAH bioactivation–related DNA damage/p53 pathways. Overall, these data, through identifying genes and signaling pathways targeted by PAHs in human macrophages, may contribute to better understand the molecular basis of the immunotoxicity of these environmental contaminants.

4 February 2014 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
LPLaurie Prigent
Laurie Prigent
MRMarc Robineau
Marc Robineau
SJStéphane Jouneau
Stéphane Jouneau
CMClaudie Morzadec
Claudie Morzadec
LLLaetitia Louarn
Laetitia Louarn
LSLydie SPARFEL
Lydie SPARFEL
The aryl hydrocarbon receptor (AhR) is a ligand‐dependent transcription factor that mediates immunosuppression caused by a variety of environmental contaminants, such as polycyclic aromatic hydrocarbons or dioxins. Recent evidence suggests that AhR plays an important role in T‐cell‐mediated immune responses by affecting the polarization and differentiation of activated T cells. However, the regulation of AhR expression in activated T cells remains poorly characterized. In the present study, we used purified human T cells stimulated with anti‐CD3 and anti‐CD28 Abs to investigate the effect of T‐cell activation on AhR mRNA and protein expression. The expression of AhR mRNA increased significantly and rapidly after T‐cell activation, identifying AhR as an immediate‐early activation gene. AhR upregulation occurred in all of the T‐cell subtypes, and is associated with its nuclear translocation and induction of the cytochromes P‐450 1A1 and 1B1 mRNA expression in the absence of exogenous signals. In addition, the use of an AhR antagonist or siRNA‐mediated AhR knockdown significantly inhibited IL‐22 expression, suggesting that expression and functional activation of AhR is necessary for the secretion of IL‐22 by activated T cells. In conclusion, our data support the idea that AhR is a major player in T‐cell physiology.

1 August 2017 in Biochemical Pharmacology
Verified
Journal Article
Closed access
MLMarie Liamin
Marie Liamin
EBElisa Boutet-Robinet
Elisa Boutet-Robinet
EJEmilien L. Jamin
Emilien L. Jamin
MFMorgane Fernier
Morgane Fernier
LKLaure Khoury
Laure Khoury
LSLydie SPARFEL
Lydie SPARFEL

Verified
Journal Article
Open access
PDF file
MLMarie Liamin
Marie Liamin
HMHélène Le Mentec
Hélène Le Mentec
BEBertrand Evrard
Bertrand Evrard
LHLaurence Huc
Laurence Huc
FCFrédéric Chalmel
Frédéric Chalmel
LSLydie SPARFEL
Lydie SPARFEL
Polycyclic aromatic hydrocarbons (PAHs) are widely distributed environmental contaminants, known to affect T lymphocytes. However, the molecular targets and pathways involved in their immunotoxic effects in human T lymphocytes remain unknown. Here, we analyzed the gene expression profile of primary human T lymphocytes treated with the prototypical PAH, benzo[α]pyrene (B[α]P), using a microarray-based transcriptome analysis. After a 48 h exposure to B[α]P, we identified 158 genes differentially expressed in T lymphocytes, including not only genes well-known to be affected by PAHs such as the cytochromes P450 (CYP) 1A1 and 1B1, but also others not previously shown to be targeted by B[α]P such as genes encoding the gap junction beta (GJB)-2 and 6 proteins. Functional enrichment analysis revealed that these candidates were significantly associated with the aryl hydrocarbon (AhR) and interferon (IFN) signaling pathways; a marked alteration in T lymphocyte recruitment was also observed. Using functional tests in transwell migration experiments, B[α]P was then shown to significantly decrease the chemokine (C-X-C motif) ligand 12-induced chemotaxis and transendothelial migration of T lymphocytes. In total, this study opens the way to unsuspected responsive pathway of interest, i.e., T lymphocyte migration, thus providing a more thorough understanding of the molecular basis of the immunotoxicity of PAHs.

17 April 2023 in Environmental Pollution
Verified
Journal Article
Closed access
RSRima Souki
Rima Souki
JAJérémy Amosse
Jérémy Amosse
VGValentine Genêt
Valentine Genêt
MGMorgane Le Gall
Morgane Le Gall
BSBenjamin Saintpierre
Benjamin Saintpierre
LSLydie SPARFEL
Lydie SPARFEL

20 September 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
JAJérémy Amossé
Jérémy Amossé
RSRima Souki
Rima Souki
MHMaguy El Hajjar
Maguy El Hajjar
MMMarie Marques
Marie Marques
VGValentine Genêt
Valentine Genêt
LSLydie SPARFEL
Lydie SPARFEL
Exposure to polycyclic aromatic hydrocarbons (PAHs), ubiquitously environmental contaminant, leads to the development of major toxic effects on human health, such as carcinogenic and immunosuppressive alterations reported for the most studied PAH, i.e., benzo(a)pyrene (B(a)P). In order to assess the risk associated with this exposure, it is necessary to have predictive biomarkers. Thus, extracellular vesicles (EVs) and their microRNA (miRNA) contents, have recently been proposed as potentially interesting biomarkers in Toxicology. Our study here explores the use of vesicles secreted and found in blood fluids, and their miRNAs, as biomarkers of exposure to B(a)P alone and within a realistic occupational mixture. We isolated EVs from primary human cultured blood mononuclear cells (PBMCs) and rat plasma after PAH exposure and reported an increased EV production by B(a)P, used either alone or in the mixture, in vitro and in vivo. We then investigated the association of this EV release with the blood concentration of the 7,8,9,10-hydroxy (tetrol)-B(a)P reactive metabolite, in rats. By performing RNA-sequencing (RNA-seq) of miRNAs in PBMC-derived EVs, we analyzed miRNA profiles and demonstrated the regulation of the expression of miR-342-3p upon B(a)P exposure. We then validated B(a)P-induced changes of miR-342-3p expression in vivo in rat plasma-derived EVs. Overall, our study highlights the feasibility of using EVs and their miRNA contents, as biomarkers of PAH exposure and discusses their potential in environmental Toxicology.